Showing results (61-70 of 161) with videos related to

Sort By:
Pageof 17
Headache|February 11, 2020
A Randomized Trial to Evaluate OnabotulinumtoxinA for Prevention of Headaches in Adolescents With Chronic MigrainePaul K Winner, Marielle Kabbouche, Marcy Yonker, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|December 8, 2010
OnabotulinumtoxinA treatment of mild glabellar lines in reposeAlastair Carruthers, Jean Carruthers, Xiaofang Lei, et al.
Headache|July 1, 2020
Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative ReviewRami Burstein, Andrew M Blumenfeld, Stephen D Silberstein, et al.
Journal of the Neurological Sciences|September 9, 2019
Minimal clinically important change in patients with cervical dystonia: Results from the CD PROBE studyKhashayar Dashtipour, Zoltan Mari, Joseph Jankovic, et al.
Drug Discovery Today|June 28, 2019
Neurobiology and therapeutic utility of neurotoxins targeting postsynaptic mechanisms of neuromuscular transmissionNaira M Ayvazyan, Valerie B O'Leary, J Oliver Dolly, et al.
The International Journal of Biochemistry & Cell Biology|July 29, 2014
New inhibitors of the Kvβ2 subunit from mammalian Kv1 potassium channelsKumari Alka, J Oliver Dolly, Barry J Ryan, et al.
The International Journal of Biochemistry & Cell Biology|September 14, 2010
Substrate profiling and aldehyde dismutase activity of the Kvβ2 subunit of the mammalian Kv1 potassium channelKumari Alka, Barry J Ryan, J Oliver Dolly, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 12, 2002
Severe generalized dystonia due to primary putaminal degeneration: case report and review of the literatureRuth H Walker, Dushyant P Purohit, Paul F Good, et al.
Pageof 17